Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma.
Assad A, Barletta F, Incesu RB, Scheipner L, Morra S, Baudo A, Garcia CC, Tian Z, Ahyai S, Longo N, Chun FKH, Shariat SF, Tilki D, Briganti A, Saad F, Karakiewicz PI. Assad A, et al. Among authors: briganti a. Urol Oncol. 2024 Apr 22:S1078-1439(24)00423-X. doi: 10.1016/j.urolonc.2024.04.003. Online ahead of print. Urol Oncol. 2024. PMID: 38653591
Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients.
Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Touma N, Tian Z, Saad F, Creta M, Califano G, Celentano G, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: briganti a. Urol Oncol. 2024 Feb;42(2):31.e1-31.e8. doi: 10.1016/j.urolonc.2023.10.013. Epub 2023 Dec 14. Urol Oncol. 2024. PMID: 38101989
Regional differences in upper tract urothelial carcinoma patients across the United States.
Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Touma N, Tian Z, Saad F, Califano G, la Rocca R, Capece M, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: briganti a. Urol Oncol. 2024 May;42(5):162.e1-162.e10. doi: 10.1016/j.urolonc.2024.01.034. Epub 2024 Feb 9. Urol Oncol. 2024. PMID: 38336499
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
Tappero S, Barletta F, Piccinelli ML, Cano Garcia C, Incesu RB, Morra S, Scheipner L, Tian Z, Parodi S, Dell'Oglio P, Palumbo C, Briganti A, De Cobelli O, Chun FKH, Graefen M, Longo N, Ahyai S, Saad F, Shariat SF, Suardi N, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: briganti a. Eur Urol Focus. 2023 Sep;9(5):742-750. doi: 10.1016/j.euf.2023.02.010. Epub 2023 Mar 9. Eur Urol Focus. 2023. PMID: 36906483
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma.
Piccinelli ML, Morra S, Tappero S, Cano Garcia C, Barletta F, Incesu RB, Scheipner L, Baudo A, Tian Z, Luzzago S, Mistretta FA, Ferro M, Saad F, Shariat SF, Carmignani L, Ahyai S, Tilki D, Briganti A, Chun FKH, Terrone C, Longo N, de Cobelli O, Musi G, Karakiewicz PI. Piccinelli ML, et al. Among authors: briganti a. Cancers (Basel). 2023 Apr 5;15(7):2155. doi: 10.3390/cancers15072155. Cancers (Basel). 2023. PMID: 37046815 Free PMC article.
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA.
Scheipner L, Tappero S, Piccinelli ML, Barletta F, Garcia CC, Incesu RB, Morra S, Baudo A, Tian Z, Saad F, Shariat SF, Terrone C, De Cobelli O, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, Pichler M, Hutterer G, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: briganti a. World J Urol. 2023 Nov;41(11):2991-3000. doi: 10.1007/s00345-023-04589-4. Epub 2023 Sep 27. World J Urol. 2023. PMID: 37755519 Free PMC article.
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis.
Morra S, Incesu RB, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Siech C, Goyal JA, Tian Z, Saad F, Califano G, la Rocca R, Capece M, Shariat SF, Ahyai S, Carmignani L, de Cobelli O, Musi G, Tilki D, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Morra S, et al. Among authors: briganti a. Cancers (Basel). 2023 Sep 10;15(18):4498. doi: 10.3390/cancers15184498. Cancers (Basel). 2023. PMID: 37760467 Free PMC article.
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
Rajwa P, Quhal F, D'Andrea D, Korn S, Petrov P, Yanagisawa T, Kawada T, Motlagh RS, Mostafaei H, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Nyirády P, Abufaraj M, Marra G, Gandaglia G, Briganti A, Karakiewicz P, Ye DW, Haydter M, Chlosta P, Comperat E, Enikeev D, Shariat SF. Rajwa P, et al. Among authors: briganti a. Arab J Urol. 2023 Apr 3;21(4):241-247. doi: 10.1080/2090598X.2023.2196911. eCollection 2023. Arab J Urol. 2023. PMID: 38178943 Free PMC article.
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.
Zattoni F, Pereira LJP, Marra G, Valerio M, Olivier J, Puche-Sanz I, Rajwa P, Maggi M, Campi R, Amparore D, De Cillis S, Junlong Z, Guo H, La Bombarda G, Fuschi A, Veccia A, Ditonno F, Marquis A, Barletta F, Leni R, Serni S, Kasivisvanathan V, Antonelli A, Dal Moro F, Rivas JG, van den Bergh RCN, Briganti A, Gandaglia G, Novara G. Zattoni F, et al. Among authors: briganti a. World J Urol. 2023 Nov;41(11):3357-3366. doi: 10.1007/s00345-023-04578-7. Epub 2023 Sep 27. World J Urol. 2023. PMID: 37755520 Free PMC article.
1,477 results